Nothing Special   »   [go: up one dir, main page]

FI106120B - Menetelmä uusien D-vitamiinianalogien valmistamiseksi - Google Patents

Menetelmä uusien D-vitamiinianalogien valmistamiseksi Download PDF

Info

Publication number
FI106120B
FI106120B FI950023A FI950023A FI106120B FI 106120 B FI106120 B FI 106120B FI 950023 A FI950023 A FI 950023A FI 950023 A FI950023 A FI 950023A FI 106120 B FI106120 B FI 106120B
Authority
FI
Finland
Prior art keywords
compound
formula
hydroxy
compounds
prot
Prior art date
Application number
FI950023A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI950023A (fi
FI950023A0 (fi
Inventor
Claus Aage Svensgaard Bretting
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI950023A publication Critical patent/FI950023A/fi
Publication of FI950023A0 publication Critical patent/FI950023A0/fi
Application granted granted Critical
Publication of FI106120B publication Critical patent/FI106120B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI950023A 1992-07-03 1995-01-02 Menetelmä uusien D-vitamiinianalogien valmistamiseksi FI106120B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929214202A GB9214202D0 (en) 1992-07-03 1992-07-03 Chemical compounds
GB9214202 1992-07-03
PCT/DK1993/000196 WO1994001398A1 (en) 1992-07-03 1993-06-07 Vitamin d analogues
DK9300196 1993-06-07

Publications (3)

Publication Number Publication Date
FI950023A FI950023A (fi) 1995-01-02
FI950023A0 FI950023A0 (fi) 1995-01-02
FI106120B true FI106120B (fi) 2000-11-30

Family

ID=10718182

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950023A FI106120B (fi) 1992-07-03 1995-01-02 Menetelmä uusien D-vitamiinianalogien valmistamiseksi

Country Status (17)

Country Link
US (1) US5545633A (ru)
EP (1) EP0648207B1 (ru)
JP (1) JPH08504746A (ru)
KR (1) KR100285146B1 (ru)
AT (1) ATE150013T1 (ru)
AU (1) AU667378B2 (ru)
CA (1) CA2131631A1 (ru)
DE (1) DE69308852T2 (ru)
DK (1) DK0648207T3 (ru)
ES (1) ES2101319T3 (ru)
FI (1) FI106120B (ru)
GB (1) GB9214202D0 (ru)
GR (1) GR3023407T3 (ru)
HU (1) HU222775B1 (ru)
NZ (1) NZ253026A (ru)
RU (1) RU2114825C1 (ru)
WO (1) WO1994001398A1 (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
EP0717034B1 (en) * 1994-12-14 1999-04-07 Duphar International Research B.V Vitamin D compounds and method of preparing these compounds
TW422696B (en) 1995-03-20 2001-02-21 Katsuhiko Mukai Ophthalmic composition containing active vitamin D
GB9526208D0 (en) * 1995-12-21 1996-02-21 Res Inst Medicine Chem Chemical compounds
GB9721156D0 (en) * 1997-10-06 1997-12-03 Leo Pharm Prod Ltd Novel vitamin d analogues
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DK1436321T3 (da) 2001-10-19 2006-11-13 Isotechnika Inc Syntese af cyclosporinanaloger
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
NZ555277A (en) * 2004-11-22 2010-12-24 Wisconsin Alumni Res Found 2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses
US8193169B2 (en) * 2006-04-06 2012-06-05 Wisconsin Alumni Research Foundation (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
US7879829B2 (en) * 2008-07-10 2011-02-01 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2-dihydrofuran ring
US7648974B1 (en) * 2008-07-10 2010-01-19 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 3,2-dihydrofuran ring
US7888339B2 (en) 2008-07-10 2011-02-15 Wisconsin Alumni Research Foundation 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
US8399439B2 (en) 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
US7893043B2 (en) 2008-07-10 2011-02-22 Wisconsin Alumni Research Foundation 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
US8193170B2 (en) * 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US7713953B2 (en) * 2008-07-10 2010-05-11 Wisconsin Alumni Research Foundation 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
US8222236B2 (en) * 2008-07-10 2012-07-17 Wisconsin Alumni Research Foundation 2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
AR072511A1 (es) * 2008-07-15 2010-09-01 Theracos Inc Derivados deuterados de bencilbenceno y metodos de uso. composicion farmaceutica.
MX339746B (es) 2009-01-27 2016-06-08 Berg Llc Vitamina d3 y análogos de la misma para aliviar efectos secundarios asociados con la quimioterapia.
WO2011019617A2 (en) 2009-08-14 2011-02-17 Cytotech Labs, Llc Vitamin d3 and analogs thereof for treating alopecia
WO2011041579A2 (en) 2009-10-02 2011-04-07 Wisconsin Alumni Research Foundation (20S,22E)-2-METHYLENE-19-NOR-22-ENE-1α,25-DIHYDROXYVITAMIN D3 ANALOGS
WO2011041596A2 (en) 2009-10-02 2011-04-07 Wisconsin Alumni Research Foundation 19-nor-vitamin d analogs with 1,2-or 3,2-cyclopentene ring
JP6059716B2 (ja) 2011-06-03 2017-01-11 ウイスコンシン アラムニ リサーチ ファンデーション (22E)−2−メチレン−26,27−シクロ−22−デヒドロ−1α−ヒドロキシ−19−ノルビタミンD3誘導体
WO2013003307A1 (en) 2011-06-28 2013-01-03 Wisconsin Alumni Research Foundation 2-methylene-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs
WO2013012644A1 (en) 2011-07-18 2013-01-24 Wisconsin Alumni I Research Foundation 2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs
US9416102B2 (en) 2013-01-23 2016-08-16 Wisconsin Alumni Research Foundation (22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
CN105492081A (zh) 2013-05-29 2016-04-13 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发
WO2016083325A1 (en) 2014-11-25 2016-06-02 Jan Faergemann Treatment of skin atrophy with a combination of triiodothyroacetic acid (triac) and dehydroepiandrosterone (dhea)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i

Also Published As

Publication number Publication date
HU9402484D0 (en) 1994-11-28
CA2131631A1 (en) 1994-01-20
DE69308852D1 (de) 1997-04-17
ATE150013T1 (de) 1997-03-15
US5545633A (en) 1996-08-13
FI950023A (fi) 1995-01-02
KR100285146B1 (ko) 2001-04-02
GR3023407T3 (en) 1997-08-29
EP0648207B1 (en) 1997-03-12
ES2101319T3 (es) 1997-07-01
FI950023A0 (fi) 1995-01-02
WO1994001398A1 (en) 1994-01-20
GB9214202D0 (en) 1992-08-12
HUT68025A (en) 1995-05-29
RU94046411A (ru) 1996-10-10
RU2114825C1 (ru) 1998-07-10
AU4311193A (en) 1994-01-31
HU222775B1 (hu) 2003-10-28
JPH08504746A (ja) 1996-05-21
EP0648207A1 (en) 1995-04-19
KR950700876A (ko) 1995-02-20
DE69308852T2 (de) 1997-11-27
NZ253026A (en) 1997-07-27
DK0648207T3 (da) 1997-06-23
AU667378B2 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
FI106120B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
FI103791B (fi) Menetelmä ja välituote uusien D-vitamiinianalogien valmistamiseksi
JP3553591B2 (ja) 新規ビタミンd類似体
FI92929B (fi) Menetelmä uusien farmaseuttisesti vaikuttavien vitamiini D analogien valmistamiseksi
FI108225B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
RU2128168C1 (ru) Аналоги витамина d3, способы из получения, фармацевтическая композиция и способ лечения
JP3773253B2 (ja) 新規ビタミンd類似体
US5401732A (en) Vitamin D analogues
FI109686B (fi) Menetelmä uusien D-vitamiinianalogien valmistamiseksi
US5994332A (en) Vitamin D analogues
US5612325A (en) Vitamin D analogues having a halogen-or azido- substituted side chain